Mounjaro scores FDA approval to reduce CV risk; Teva to buy an approved drug
Plus news about AusperBio and Samsung Biologics. Eli Lilly’s Mounjaro wins heart approval: The blockbuster drug, whose generic name is tirzepatide, was approved on Friday to reduce the risk of major ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Roivant's dermatomyositis drug Lisraya snags FDA approval endpoints.news